Drugs / Lispro mix 75/25
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00551538 Comparator | May 2003 → Dec 2004 | type 2 diabetes mellitus | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lispro mix 75/25 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00551538 ↗ |
| Route | Subcutaneous | “SC injection” NCT00551538 ↗ |